New vaccine strategy targets SARS-CoV-2's stable S2 subunit,

Study presents a new SARS-CoV-2 S2 subunit vaccine that elicits strong antibody responses against various sarbecovirus strains, including challenging variants like XBB.1.5, demonstrating its potential as a broadly effective and stable vaccine option.

Related Keywords

, Human Embryonic Kidney , Coronavirus Disease Covid 19 , Cars , Ars Cov 2 , Vaccine , Virus , Ntibody , Ntigen , Fell , Contamination , Coronavirus , Efficacy , Electron , Electron Microscopy , Lisa , Immune Response , Kidney , Icroscopy , Utation , Mycoplasma , Protein , Research , Espiratory , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Spike Protein , Yndrome ,